Publications

Hayes Publications are available through the Hayes Knowledge Center, a portal to world-class research and unbiased analyses on the clinical, financial, and risk impacts of emerging, controversial, and disruptive healthcare technologies.

Every Hayes publication is developed by multidisciplinary teams of clinicians and scientists using rigorous methods grounded in internally recognized standards for systematic review and Health Technology Assessment. Learn more about these evidence resources and see sample titles below.

See below for some of our recent publications.

Transpose RT System for Rotator Cuff Tendinopathy

The Transpose RT system (formerly known as Transpose Ultra) is a device for enzymatic isolation and preparation of uncultured unmodified autologous adipose-derived regenerative cells (UA-ADRCs) for injection therapy. This therapy is proposed for stand-alone point-of-care treatment of partial-thickness rotator cuff tears.

Exagamglogene Autotemcel (Casgevy; Vertex/CRISPR) for Sickle Cell Disease

Exagamglogene autotemcel (Casgevy; Vertex Pharmaceuticals and CRISPR Therapeutics) is an autologous, genome-edited, hematopoietic stem cell-based gene therapy indicated for the treatment of sickle cell disease (SCD) in patients aged 12 years and older with recurrent vaso-occlusive crises (VOCs).